Clinical Trial

New Method to Differentiate Benign and Malignant Pulmonary Nodules.

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 18, 2024 (before its estimated January 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational clinical trial is to establish a new method for differentiating benign and malignant pulmonary nodules by peripheral blood detection in patients with pulmonary nodules (\<3cm). The main questions it aims to answer is: How to combine blood metabolomic mass spectrometry detection and artificial intelligence image analysis to establish a new model for differentiating benign and malignant pulmonary nodules. Participants will be asked provide 4 mL peripheral blood for the test.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-09-21; most recent amendment 2024-12-13.
Status change: Not Yet Recruiting → Recruiting 2023-10-18
Trial Details
NCT Number NCT06056999
Lead Sponsor China-Japan Friendship Hospital
Conditions Pulmonary Nodules
Enrollment 150 participants
Start Date 2023-09-29
Primary Completion 2025-01 (estimated)
Study Completion 2025-07 (estimated)
Updated on ClinicalTrials.gov 2024-12-18